This activity is part of the Frankly Speaking with Dr. Frank Domino podcast series.
Podcast
Continuous Glucose Monitoring—What’s All the Hype? - Frankly Speaking EP 236Guest: Robert A. Baldor, MD, FAAFP
Music Credit: Richard Onorato
Continuous glucose monitoring (CGM) for patients with diabetes has been available for several years now, but its utility in managing diabetes care is unclear. Join us to discuss the results of a systematic review examining the benefits of CGM for patients with both type 1 and type 2 diabetes mellitus.
Episode References and Resources:
- Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(5):1146-1156.
- Implementing Continuous Glucose Monitoring in Clinical Practice. www.aafp.org/fpm March/April 2021
- Longo R, Sperling S. Personal versus professional continuous glucose monitoring: when to use which on whom. Diabetes Spectr. 2019;32(3):183-193.
Begin
Already listened on another platform?
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 8/9/2021
Expiration Date: 8/9/2022
Topics
Learning Objectives
- Explain the methods for continuous glucose monitoring (CGM)
- Assess the data on the benefits of CGM for patients with diabetes
- Appreciate the complexities for ordering CGM for patients with diabetes
Faculty
Frank J. Domino, MD
Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA
Robert A. Baldor, MD, FAAFP
Professor and Chairman, Dept of Family Medicine
UMass Medical School/Baystate
Supporters and Partners
Supported by
Not Applicable
Education Partner
Not Applicable